Collaborations
Stem cell focused company, Wayne State collaborate on prostate cancer research
Published in Cancer Weekly, December 13th, 2005
Chemokine Therapeutics Corp. (CTI), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, cardiovascular, and infectious diseases, has executed an agreement with cancer researchers at the Wayne State University School of Medicine in Michigan, providing access to the company's lead anticancer compound CTCE-9908 for a planned series of novel preclinical and in-vitro experiments.
The studies will evaluate the ability of CTCE-9908 to inhibit the signaling and function of the CXCR4 receptor found on prostate cancer cells.
The CXCR4 receptor, present on many common cancers, has been observed to contribute to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-12-13)
More Articles from Cancer Weekly
- Cancer Risk Factors
Night work might be related to breast cancer risk - Cancer Therapy
Interferon treatment increases virotherapy for advanced hepatocellular carcinoma - Healthcare Costs
Taxane test-dose reduced cost associated with hypersensitivity reaction - Anemia
First long-term phase II study of CERA in renal patients shows control of anemia - Apoptosis
2-cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) induced apoptosis in pancreatic cancer - Apoptosis
Biological stimuli of neuroblastoma cell response analyzed - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
